HIND
Vyome Holdings, Inc.NASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$15.65M
P/E Ratio
—
EPS
$-1.56
Beta
—
52W High
$33.16
52W Low
$1.75
50-Day MA
$2.15
200-Day MA
$4.43
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Vyome Holdings, Inc.
Vyome Holdings Inc., a clinical-stage healthcare company, develops therapeutic products targeting immuno-inflammatory and rare diseases in the United States and global markets. The company is headquartered in Princeton, New Jersey.
Fundamentals
| Revenue (TTM) | 152,720 |
| Gross Profit (TTM) | 81,000 |
| EBITDA | $-3.67M |
| Operating Margin | -3577.00% |
| Return on Equity | -666.00% |
| Return on Assets | -39.50% |
| Revenue/Share (TTM) | $0.04 |
| Book Value | $0.96 |
| Price-to-Book | 2.32 |
| Price-to-Sales (TTM) | 102.48 |
| EV/Revenue | 45.04 |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -84.10% |
| Shares Outstanding | $7.02M |
| Float | $3.25M |
| % Insiders | 52.89% |
| % Institutions | 1.52% |
Historical Volatility
HV 10-Day
57.47%
HV 20-Day
59.05%
HV 30-Day
56.05%
HV 60-Day
61.41%
HV Rank
—
Volatility is currently expanding
Analyst Ratings
Consensus ($11.50 target)
1
Strong BuyMore HEALTHCARE Stocks
Data last updated: 5/25/2026